Roche breast cancer drug Perjeta helped extend patients' lives by over a year in clinical trial Roche's Perjeta drug has significantly extended the lives of patients with metastatic breast cancer by over one year. Researchers said the improvement in median survival time is unprecedented. by Rhodi Lee
Healthy Living/Wellness Doctor is tired? 70 percent of young cancer doctors showing signs of burnout by Sumit Passary